Ahmad Qasim Iftikhar 4
4 · IO Biotech, Inc. · Filed Mar 18, 2024
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Ahmad Qasim Iftikhar
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-15+280,000→ 280,000 totalExercise: $1.65Exp: 2034-03-15→ Common Stock (280,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.